| Michelle Bachtold, PA-C | |
|
8640 Sudley Rd Ste 201, Manassas, VA 20110-4404 | |
| (703) 368-6819 | |
| (703) 330-2923 |
| Full Name | Michelle Bachtold |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Experience | 16 Years |
| Location | 8640 Sudley Rd Ste 201, Manassas, Virginia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245475607 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363AM0700X | Physician Assistant - Medical | 0110002893 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Novant Prince William Medical Center | Manassas, VA | Hospital |
| Novant Health Uva Health Haymarket Medical Center | Haymarket, VA | Hospital |
| Fauquier Hospital | Warrenton, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Gastroenterology Associates Pc | 2466449228 | 14 |
News Archive
The International Society for Cellular Therapy, the global society of clinicians, researchers, regulatory specialists, technologists, and industry partners dedicated to the translation of cellular therapy into safe and effective therapies to improve patients' lives, today announces they have awarded London as the host city for the landmark ISCT 2017 Annual Meeting to be held on May 3-6, at ExCeL London Exhibition and Convention Centre, UK to celebrate the Society's 25th silver jubilee year. More than 1,600 international delegates are expected to attend.
Decision Resources finds that the drug market for key hospital-treated infections that are of high interest to drug developers—most notably nosocomial pneumonia, bloodstream infections, skin and skin structure/surgical site infections and urinary tract infections—will increase from $3.3 billion in 2010 to just over $4 billion in 2020 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.
Avila Therapeutics™, Inc., a biotechnology company developing targeted covalent drugs that treat diseases through protein silencing, presented results of preclinical studies on two of its Hepatitis C Virus protease inhibitors, AVL-181 and AVL-192. These inhibitors, due to their unique mechanism of action with superior selectivity and potency, have potential as best-in-class, pan-genotype HCV therapeutics.
"Following criticism over a spate of patient deaths from adverse events during clinical trials, India has begun tightening up rules for clinical research and compensation as well as expanding its pool of medical experts," SciDev.Net reports.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michelle Bachtold, PA-C 8640 Sudley Rd Ste 201, Manassas, VA 20110-4404 Ph: (703) 368-6819 | Michelle Bachtold, PA-C 8640 Sudley Rd Ste 201, Manassas, VA 20110-4404 Ph: (703) 368-6819 |
News Archive
The International Society for Cellular Therapy, the global society of clinicians, researchers, regulatory specialists, technologists, and industry partners dedicated to the translation of cellular therapy into safe and effective therapies to improve patients' lives, today announces they have awarded London as the host city for the landmark ISCT 2017 Annual Meeting to be held on May 3-6, at ExCeL London Exhibition and Convention Centre, UK to celebrate the Society's 25th silver jubilee year. More than 1,600 international delegates are expected to attend.
Decision Resources finds that the drug market for key hospital-treated infections that are of high interest to drug developers—most notably nosocomial pneumonia, bloodstream infections, skin and skin structure/surgical site infections and urinary tract infections—will increase from $3.3 billion in 2010 to just over $4 billion in 2020 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.
Avila Therapeutics™, Inc., a biotechnology company developing targeted covalent drugs that treat diseases through protein silencing, presented results of preclinical studies on two of its Hepatitis C Virus protease inhibitors, AVL-181 and AVL-192. These inhibitors, due to their unique mechanism of action with superior selectivity and potency, have potential as best-in-class, pan-genotype HCV therapeutics.
"Following criticism over a spate of patient deaths from adverse events during clinical trials, India has begun tightening up rules for clinical research and compensation as well as expanding its pool of medical experts," SciDev.Net reports.
› Verified 7 days ago
Jacqueline Ramirez, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 8640 Sudley Rd Ste 201, Manassas, VA 20110 Phone: 703-368-6819 Fax: 703-330-2923 | |
Mr. David J Pope, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 9625 Surveyor Court, Suite 320, Manassas, VA 20110 Phone: 571-921-4877 Fax: 571-208-0585 | |
Mrs. Katherine Black, PA Physician Assistant Medicare: Medicare Enrolled Practice Location: 8100 Ashton Ave Ste 200, Manassas, VA 20109 Phone: 877-415-4116 Fax: 571-358-3941 | |
Mr. Berkley Leo Williams, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 8708 Sudley Rd, Manassas, VA 20110 Phone: 703-530-1226 Fax: 703-530-1228 | |
Mikaela Renee Worley, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 11700 Sudley Manor Dr, Manassas, VA 20109 Phone: 703-589-9695 | |
Brooke Elizabeth Huggins, Physician Assistant Medicare: Medicare Enrolled Practice Location: 8700 Sudley Rd, Manassas, VA 20110 Phone: 703-369-8000 | |
Gemima Muteba, Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 11700 Sudley Manor Dr, Manassas, VA 20109 Phone: 703-589-9695 |